Literature DB >> 2547566

Nedocromil sodium inhibition of IgE-mediated activation of human mononuclear phagocytes and platelets from asthmatics.

M Joseph1, T Thorel, A Tsicopoulos, A B Tonnel, A Capron.   

Abstract

The demonstration of a specific receptor for IgE on non-mast cell or basophil leucocytes, such as mononuclear phagocytes, eosinophils and platelets, suggests that these cells may participate directly in immunological disorders of allergy. In this study, inhibition by nedocromil sodium of IgE-dependent activation of human alveolar macrophages, blood monocytes and platelets was investigated. Nedocromil sodium produced an inhibition of IgE-mediated generation of cytotoxic molecules from monocytes and platelets together with a concomitant inhibition of their oxidative metabolism, measured by chemiluminescence. In addition, nedocromil sodium reduced the ability of alveolar macrophages to synthesise and release mediators, estimated by beta-glucuronidase activity. Furthermore, nedocromil sodium inhibited the abnormal response to aspirin of platelets from aspirin-sensitive asthmatics at therapeutic concentrations. These studies confirm that nedocromil sodium acts on a cell compartment other than the classical mast cell population in IgE-dependent allergy and asthma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547566     DOI: 10.2165/00003495-198900371-00008

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  7 in total

1.  Inhibition by nedocromil sodium of IgE-mediated activation of human mononuclear phagocytes and platelets in allergy.

Authors:  T Thorel; M Joseph; A Tsicopoulos; A B Tonnel; A Capron
Journal:  Int Arch Allergy Appl Immunol       Date:  1988

2.  Regulation of IgE-dependent antiparasite functions of rat macrophages and platelets by nedocromil sodium.

Authors:  T Thorel; M Joseph; H Vorng; A Capron
Journal:  Int Arch Allergy Appl Immunol       Date:  1988

3.  From parasites to allergy: a second receptor for IgE.

Authors:  A Capron; J P Dessaint; M Capron; M Joseph; J C Ameisen; A B Tonnel
Journal:  Immunol Today       Date:  1986-01

4.  Release of platelet-activating factor (PAF-acether) from alveolar macrophages by the calcium ionophore A23187 and phagocytosis.

Authors:  B Arnoux; D Duval; J Benveniste
Journal:  Eur J Clin Invest       Date:  1980-12       Impact factor: 4.686

5.  Investigation of alveolar macrophage function using lucigenin-dependent chemiluminescence.

Authors:  A J Williams; P J Cole
Journal:  Thorax       Date:  1981-11       Impact factor: 9.139

6.  Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients.

Authors:  M Joseph; A B Tonnel; G Torpier; A Capron; B Arnoux; J Benveniste
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

7.  Secretion of a chemotactic factor for neutrophils and eosinophils by alveolar macrophages from asthmatic patients.

Authors:  P Gosset; A B Tonnel; M Joseph; L Prin; A Mallart; J Charon; A Capron
Journal:  J Allergy Clin Immunol       Date:  1984-12       Impact factor: 10.793

  7 in total
  2 in total

Review 1.  Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

Review 2.  Novel uses for anti-platelet agents as anti-inflammatory drugs.

Authors:  S C Pitchford
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.